Archived

The mRNA technology behind Moderna’s Covid vaccine reaches the flu

The mFlusiva vaccine for older people is the first made with the mRNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid -19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu…

Coverage from 4 publishers 4 source reports
GuardianTIMECBSNYT
F.D.A. Approves Moderna’s mRNA Flu Vaccine NYTimes – Business
Update summary

What changed in this update

The shot, made by Moderna, will be available for this year's upcoming flu season.

Source coverage

Source reports

US
Guardian

The mRNA technology behind Moderna’s Covid vaccine reaches the flu

US
TIME

FDA Approves the First mRNA Flu Vaccine

The shot, made by Moderna, will be available for this year's upcoming flu season.

US
CBS

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

F.D.A. Approves Moderna’s mRNA Flu VaccineNYTimes – Business
NYT

F.D.A. Approves Moderna’s mRNA Flu Vaccine

The agency had initially refused to even review the application but reversed course after a public outcry.

Discovery

See what’s emerging. See what’s changing.

Explore stories gaining momentum and continuing events with new developments.